PERSPECTA

News from every angle

← Back to headlines

Guggenheim reiterates Buy on EyePoint stock after mixed trial data By Investing.com - Investing.com India

Guggenheim reiterates Buy on EyePoint stock after mixed trial data By Investing.com  Investing.com India

17 Aug, 17:50 — 17 Aug, 17:50
PostShare

Sources

Showing 1 of 1 sources
investing-com18h ago

Guggenheim reiterates Buy on EyePoint stock after mixed trial data By Investing.com - Investing.com India

Guggenheim reiterates Buy on EyePoint stock after mixed trial data By Investing.com  Investing.com India

Read full article →

Related Stories

Baidu Reports Fifth Consecutive Quarterly Sales Decline, Misses Revenue Estimates

19m ago

Analysts React to Home Depot Earnings Report

19m ago

Tata Sons Defers Annual Shareholder Meeting Due to Lack of Quorum

25m ago

EU Approves FedEx-Led Consortium's Acquisition of InPost

33m ago